Hemanth Prabhudev

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

James L. Alexander, Benjamin H. Mullish, Nathan Danckert et al. · EBioMedicine · 2023 · 58 citations · Full text

Life Sciences, Immunology, Microbiology +17

Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement

D Smith, Hemanth Prabhudev, Sirazum Choudhury et al. · Endocrine Connections · 2017 · 43 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Late-night salivary cortisol and cortisone should be the initial screening test for Cushing’s syndrome

Ramjan Sanas Mohamed, Biyaser Abuelgasim, Sally Barker et al. · Endocrine Connections · 2022 · 17 citations · Full text

Medicine, Endocrinology, Neuroendocrinology +16